1-3 of 3
Yin Changxin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective Evaluation of Sorafenib Combined with Chemotherapy in Newly Diagnosed Adult Core-Binding Factor Acute Myeloid Leukemia: An Open-Label, Randomized Controlled, Multicenter Phase II Trial

Pengcheng Shi, Xi Jia, Naying Liao, Yin Changxin, Huan Li, Xuejie Jiang, Guopan Yu, Jieyu Ye, Hong Qu, Yu Zhan, Chunju Wen, Yu Zhang, Qifa Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 2005–2006.
https://doi.org/10.1182/blood-2022-156348
Published: 2022
Journal Articles

The Clinical Characteristics and Efficacy of Chronic Myeloid Leukemia Patients with T315I Mutation

Chen Chen, Na Xu, PhD, Wu WanEr, Liu Liang, Xuan Zhou, PhD, Huang JiXian, Yin Changxin, Rui Cao, Qifa Liu, MD, Liu Xiaoli, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5433.
https://doi.org/10.1182/blood-2018-99-114113
Published: 2018
Journal Articles

MiR-144 Targets APP to Regulate AML1/ETO+ Leukemia Cell Migration Via p-ERK/c-Myc/MMP-2 Pathway

Fanyi Meng, Ling Jiang, PhD MD, Wei Meng, PhD, Guo-Pan Yu, MD, Yin Changxin, Zhixiang Wang, PhD, Xuejie Jiang, MD, Qifa Liu
Journal: Blood
Blood (2017) 130 (Supplement 1): 5093.
https://doi.org/10.1182/blood.V130.Suppl_1.5093.5093
Published: 2017